A novel method for calculating prevalence of multiple sclerosis in Australia

Multiple Sclerosis Journal

Volumn 19, Issue 13, 2013, Pages 1704-1711

  Palmer, Andrew J ^a   Hitchens, Peta L ^a   Simpson, Steve ^a   O'Leary, Beth ^b   Colman, Sam ^b   Taylor, Bruce V ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b PO Box 64   (Australia)

Author keywords

disease modifying therapies; Multiple sclerosis; prevalence

Indexed keywords

BETA1A INTERFERON; GLATIRAMER; INTERFERON BETA SERINE;

ARTICLE; AUSTRALIA; CALCULATION; HEALTH CARE SURVEY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LATITUDE; MEDICAL SOCIETY; MULTIPLE SCLEROSIS; PRESCRIPTION; PREVALENCE; SENSITIVITY ANALYSIS;

DISEASE MODIFYING THERAPIES; MULTIPLE SCLEROSIS; PREVALENCE;

AGE FACTORS; AUSTRALIA; DISABILITY EVALUATION; DRUG PRESCRIPTIONS; EPIDEMIOLOGIC METHODS; GEOGRAPHY; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; MULTIPLE SCLEROSIS; NATIONAL HEALTH PROGRAMS; PREVALENCE; RURAL POPULATION; TASMANIA; URBAN POPULATION;

EID: 84887567085     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513479841     Document Type: Article

References (34)

1. Access Economics. Acting positively: Strategic implications of the economic costs of MS in Australia, http://www.accesseconomics.com.au/ publicationsreports/getreport.php?report=7&id=7 (2005, accessed June 2011) http://www.deloitteaccesseconomics.com.au/publications+and+reports/ browse+reports. Last accessed February 27, 2013.
2. Palmer AJ, Colman S, O'Leary B, et al. The Economic Impact of Multiple Sclerosis in Australia in 2010. Mult Scler. 2013 ;:
3. Simpson S, Blizzard L, Otahal P, et al. Latitude is significantly associated with the prevalence of multiple sclerosis: A meta-analysis. J Neurol Neurosurg Psychiatry. 2011 ; 82: 1132-1141
4. Beretich B, Beretich T. Explaining multiple sclerosis prevalence by ultraviolet exposure: A geospatial analysis. Mult Scler. 2009 ; 15: 891-898
5. McCall MG, Brereton TL, Dawson A, et al. Frequency of multiple sclerosis in three Australian cities - Perth, Newcastle, and Hobart. J Neurol Neurosurg Psychiatry. 1968 ; 31: 1-9
6. Hammond SR, McLeod JG, Millingen KS, et al. The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Brain. 1988 ; 111: 1-25
7. McLeod JG, Hammond SR, Hallpike JF. Epidemiology of multiple sclerosis in Australia - NSW and SA survey results. Med J Aust. 1994 ;: 160
8. Barnett MH, Williams DB, Day S, et al. Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: A 35-year study. J Neurol Sci. 2003 ; 213: 1-6
9. Simpson SL, Pittas F, van der Mei I, et al. Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009. J Neurol Neurosurg Psychiatry. 2011 ; 82: 180-187
10. Poser CM, Hibberd PL, Benedikz J, et al. Analysis of the 'epidemic' of multiple sclerosis in the Faroe Islands. I. Clinical and epidemiological aspects. Neuroepidemiology. 1988 ; 7: 168-180
11. Bentzen J, Meulengracht Flachs E, Stenager E, et al. Prevalence of multiple sclerosis in Denmark 1950-2005. Mult Scler. 2010 ; 16: 520-525
12. Marrie RA, Yu N, Blanchard J, Leung S, et al. The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology. 2010 ; 74: 465-471
13. Hawkes CH, Ramkumar N, Baker R, et al. Multiple sclerosis in Latter Day Saints (Mormons). Acta Neurol Scand. 2007 ; 115: 260-264
14. Vukusic S, Van Bockstael V, Gosselin S, et al. Regional variations in the prevalence of multiple sclerosis in French farmers. J Neurol Neurosurg Psychiatry. 2007 ; 78: 707-709
15. Kurtzke JF, Beebe GW, Norman JE. Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution. Neurology. 1979 ; 29: 1228-1235
16. Baumhackl U, Eibl G, Ganzinger U, et al. Prevalence of multiple sclerosis in Austria. Results of a nationwide survey. Neuroepidemiology. 2002 ; 21: 226-234
17. Baum HM, Rothschild BB. The incidence and prevalence of reported multiple sclerosis. Ann Neurol. 1981 ; 10: 420-428
18. Kurtzke JF, Delasnerie-Laupretre N, Wallin MT. Multiple sclerosis in North African migrants to France. Acta Neurol Scand. 1998 ; 98: 302-309
19. Medicare Australia Statistics. https://www.medicareaustralia.gov.au/ statistics/pbs-item.shtml (2011, accessed 1 August 2011).
20. IMC Link Professional Advisory and Consultancy Services. Getting in touch. A report on the needs of Tasmanians with neuromuscular conditions, http://www.imc-link.com.au/wp-content/uploads/2011/03/getting-in-touch-final- report.pdf (July 2010).
21. Breslow NE, Day NE Statistical methods in cancer research. Lyon: International Agency for Research on Cancer ; 1987: 120-177.
22. Australian Bureau of Statistics. 4433.0 - Disability, aging and carers, Australia: Disability and long term health conditions, 2009, http://www.abs.gov.au/ausstats/abs@nsf/Latestproducts/4433. 0Main%20Features99992009?opendocument&tabname=Summary&prodno=4433. 0&issue=2009&num=&view= (2009).
23. Australian Bureau of Statistics. Statistical Geography Volume 1 - Australian Standard Geographical Classification (ASGC). ABS Catalogue Number 1216.0. Commonwealth of Australia July 2006. http://www.abs.gov.au/AUSSTATS/ abs@nsf/ProductsbyReleaseDate/BD1B52D132D130E7CA2573630012F67B?OpenDocument. Last accessed February 27, 2013.
24. McLeod JG, Hammond SR, Hallpike JF. Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results. Med J Aust. 1994 ; 160: 117-122
25. Tremlett H, Van der Mei I, Pittas F, et al. Adherence to the immunomodulatory drugs for multiple sclerosis: Contrasting factors affect stopping drug and missing doses. Pharmacoepidemiol Drug Saf. 2008 ; 17: 565-576
26. Australian Bureau of Statistics. Australian demographic statistics, June quarter 2012, http://www.ausstats.abs.gov.au/ausstats/subscriber.nsf/0/ A535F84F4393C62FCA257AD7000D113E/$File/31010-jun%202012.pdf (2012).
27. Australian Government Department of Immigration and Citizenship. Visas, immigration and health requirements, http://www.immi.gov.au/allforms/health- requirements/overview-health-req.htm. (accessed February 27, 2013).
28. Australian Government Department of Immigration and Citizenship. Fact sheet 2 - key facts about immigration, http://www.immi.gov.au/media/fact-sheets/ 02key.htm. (accessed February 27, 2013).
29. Barnett MH, Williams DB, Day S, et al. Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: A 35-year study. J Neurol Sci. 2003 ; 213: 1-6
30. Simmons RD, Hall CA, Gleeson P, et al. Prevalence survey of multiple sclerosis in the Australian Capital Territory. Intern Med J. 2001 ; 31: 161-167
31. Fromont A, Binquet C, Sauleau EA, et al. Geographic variations of multiple sclerosis in France. Brain. 2010 ; 133: 1889-1899
32. Ahlgren C, Oden A, Lycke J. High nationwide prevalence of multiple sclerosis in Sweden. Mult Scler. 2011 ; 17: 901-908
33. Koch-Henriksen N, Sorensen PS. Why does the north-south gradient of incidence of multiple sclerosis seem to have disappeared on the northern hemisphere?. J Neurol Sci. 2011 ; 311: 58-63
34. Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010 ; 9: 520-532